Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil

Testa, 2018, Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells, Med Sci (Basel), 6 Heinemann, 2014, FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial, Lancet Oncol, 15, 1065, 10.1016/S1470-2045(14)70330-4 Grothey, 2005, Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line, J Clin Oncol, 23, 9441, 10.1200/JCO.2005.04.4792 Grothey, 2008, New lessons from "old" chemotherapy in colorectal cancer, J Clin Oncol, 26, 4532, 10.1200/JCO.2008.17.8145 Franko, 2012, Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841, J Clin Oncol, 30, 263, 10.1200/JCO.2011.37.1039 Franko, 2016, Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database, Lancet Oncol, 17, 1709, 10.1016/S1470-2045(16)30500-9 Shin, 2009, Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance, Electrophoresis, 30, 2182, 10.1002/elps.200800806 Allen, 2006, Predicting the outcome of chemotherapy for colorectal cancer, Curr Opin Pharmacol, 6, 332, 10.1016/j.coph.2006.02.005 Kaypee, 2016, Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics, Pharmacol Ther, 162, 98, 10.1016/j.pharmthera.2016.01.011 Du, 2017, 5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer, Cancer Lett, 400, 183, 10.1016/j.canlet.2017.04.033 Tang, 2017, Downregulation of SIRT7 by 5-fluorouracil induces radiosensitivity in human colorectal cancer, Theranostics, 7, 1346, 10.7150/thno.18804 Murr, 2006, Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks, Nat Cell Biol, 8, 91, 10.1038/ncb1343 Norio, 2006, DNA replication: the unbearable lightness of origins, EMBO Rep, 7, 779, 10.1038/sj.embor.7400766 Gadhia, 2004, Histone Acetyltransferase Assays in Drug and Chemical Probe Discovery Seto, 2014, Erasers of histone acetylation: the histone deacetylase enzymes, Cold Spring Harb Perspect Biol, 6, a018713, 10.1101/cshperspect.a018713 Verdin, 2015, 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond, Nat Rev Mol Cell Biol, 16, 258, 10.1038/nrm3931 Choudhary, 2014, The growing landscape of lysine acetylation links metabolism and cell signalling, Nat Rev Mol Cell Biol, 15, 536, 10.1038/nrm3841 Kouzarides, 2007, SnapShot: Histone-modifying enzymes, Cell, 131, 822, 10.1016/j.cell.2007.11.005 Liu, 1999, p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage, Mol Cell Biol, 19, 1202, 10.1128/MCB.19.2.1202 Liu, 2000, Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF, Mol Cell Biol, 20, 5540, 10.1128/MCB.20.15.5540-5553.2000 Xenaki, 2008, PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia, Oncogene, 27, 5785, 10.1038/onc.2008.192 Brandl, 2012, Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress, J Mol Cell Biol, 4, 284, 10.1093/jmcb/mjs013 Wagner, 2014, Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis, Biochim Biophys Acta, 1846, 524 Okumura, 2006, PCAF modulates PTEN activity, J Biol Chem, 281, 26562, 10.1074/jbc.M605391200 Patel, 2004, The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60, Mol Cell Biol, 24, 10826, 10.1128/MCB.24.24.10826-10834.2004 Zheng, 2013, Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling, Mol Cancer, 12, 96, 10.1186/1476-4598-12-96 Ying, 2010, The p300/CBP associated factor is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome, Cancer Biol Ther, 9, 312, 10.4161/cbt.9.4.10748 Wan, 2015, PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression, Nucleic Acids Res, 43, 3591, 10.1093/nar/gkv238 Zhang, 2015, PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells, Tumour Biol, 36, 1455, 10.1007/s13277-014-2522-8 Wang, 2013, Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer, PLoS One, 8, e78083, 10.1371/journal.pone.0078083 Zhao, 2017, The Nogo-B receptor promotes Ras plasma membrane localization and activation, Oncogene, 36, 3406, 10.1038/onc.2016.484 AV Paschall, 2016, CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype, Oncotarget, 7, 78698, 10.18632/oncotarget.12168 Chi, 2010, Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers, Nat Rev Cancer, 10, 457, 10.1038/nrc2876 Albert, 2010, Histone methyltransferases in cancer, Semin Cell Dev Biol, 21, 209, 10.1016/j.semcdb.2009.10.007 Zaidi, 2017, Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer, Mol Cell Biol, 37, 10.1128/MCB.00352-17 Porter, 1999, Emerging roles of caspase-3 in apoptosis, Cell Death Differ, 6, 99, 10.1038/sj.cdd.4400476 Tewari, 1995, Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase, Cell, 81, 801, 10.1016/0092-8674(95)90541-3 Liu, 2015, Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry, Med Sci Monit Basic Res, 21, 15, 10.12659/MSMBR.893327 Jin, 2018, Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel, Cancer Lett, 419, 233, 10.1016/j.canlet.2018.01.054 Zhang, 2015, MicroRNA-520g confers drug resistance by regulating p21 expression in colorectal cancer, J Biol Chem, 290, 6215, 10.1074/jbc.M114.620252 Noro, 2010, Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression, Cancer Sci, 101, 1424, 10.1111/j.1349-7006.2010.01559.x Harbour, 1999, Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1, Cell, 98, 859, 10.1016/S0092-8674(00)81519-6 Harbour, 2000, Rb function in cell-cycle regulation and apoptosis, Nat Cell Biol, 2, E65, 10.1038/35008695 Shah, 2001, Cell cycle-mediated drug resistance: an emerging concept in cancer therapy, Clin Cancer Res, 7, 2168 Hu, 2016, Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway, Hepatology, 64, 1559, 10.1002/hep.28747 Dong, 2016, Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein, Oncotarget, 7, 8850, 10.18632/oncotarget.7091 Longley, 2003, 5-fluorouracil: mechanisms of action and clinical strategies, Nat Rev Cancer, 3, 330, 10.1038/nrc1074 Huhn, 2013, Targeting DNA double-strand break signalling and repair: recent advances in cancer therapy, Swiss Med Wkly, 143, w13837 Ijichi, 2014, Cell-cycle distribution and Thymidilate Synthatase (TS) expression correlate with 5-FU resistance in head and neck carcinoma cells, Anticancer Res, 34, 2907 Horibe, 2015, Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins, Life Sci, 124, 31, 10.1016/j.lfs.2015.01.011 Hui, 2002, Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells, Cancer Res, 62, 6916 Di Stefano, 2005, HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage, Oncogene, 24, 5431, 10.1038/sj.onc.1208717 Luo, 2000, Deacetylation of p53 modulates its effect on cell growth and apoptosis, Nature, 408, 377, 10.1038/35042612 Wagner, 2015, Sumoylation of HDAC2 promotes NF-kappaB-dependent gene expression, Oncotarget, 6, 7123, 10.18632/oncotarget.3344 Engeland, 2018, Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM, Cell Death Differ, 25, 114, 10.1038/cdd.2017.172 Fischer, 2017, Census and evaluation of p53 target genes, Oncogene, 36, 3943, 10.1038/onc.2016.502 Barlev, 2001, Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases, Mol Cell, 8, 1243, 10.1016/S1097-2765(01)00414-2 Tang, 2008, Acetylation is indispensable for p53 activation, Cell, 133, 612, 10.1016/j.cell.2008.03.025 Love, 2012, The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3, Cell Cycle, 11, 2458, 10.4161/cc.20864 Moore, 2013, DNA methylation and its basic function, Neuropsychopharmacology, 38, 23, 10.1038/npp.2012.112 McGrath, 2015, Targeting histone lysine methylation in cancer, Pharmacol Ther, 150, 1, 10.1016/j.pharmthera.2015.01.002 Copeland, 2009, Protein methyltransferases as a target class for drug discovery, Nat Rev Drug Discov, 8, 724, 10.1038/nrd2974 Hublitz, 2009, Mechanisms of transcriptional repression by histone lysine methylation, Int J Dev Biol, 53, 335, 10.1387/ijdb.082717ph Barski, 2007, High-resolution profiling of histone methylations in the human genome, Cell, 129, 823, 10.1016/j.cell.2007.05.009